Tolerance
What is tolerance?
Tolerance is a biological adaptation where your body becomes less responsive to a substance after repeated exposure. The same dose that produced noticeable effects initially now produces weaker — or no — effects. To achieve the original effect, you'd need a higher dose.
For psychedelics, tolerance development is remarkably rapid — faster than for almost any other drug class. This has profound implications for microdosing practice.
How psychedelic tolerance works
The mechanism: receptor downregulation
When a psychedelic activates 5-HT2A receptors, the cells respond by pulling receptors inside the cell (internalization). With fewer receptors on the surface, the same amount of psychedelic has fewer targets to bind to, producing a weaker effect.
The timeline
| Time | Tolerance level | Practical meaning |
|---|---|---|
| Single dose | 0% (no tolerance) | Full effect |
| Day 2 (consecutive) | ~50–70% | Significantly reduced effects |
| Day 3 (consecutive) | ~80–90% | Minimal effects |
| Day 4+ (consecutive) | ~95%+ | Near-complete tolerance |
| After 2 days off | ~30–50% remaining | Partial recovery |
| After 5–7 days off | ~0–10% remaining | Near-complete reset |
| After 14 days off | 0% | Full reset |
Why psychedelic tolerance is special
- Speed — develops within 1–3 days (compared to weeks for most drugs)
- Completeness — can become nearly total with consecutive dosing
- Cross-substance — applies to ALL 5-HT2A agonists, not just the one used
- Recovery — resets relatively quickly (5–14 days)
- No dose escalation spiral — unlike opioids or stimulants, psychedelic tolerance doesn't typically lead to compulsive dose escalation
Why tolerance matters for microdosing
Protocol design
Every microdosing protocol includes rest days specifically to manage tolerance:
- Fadiman (1 on, 2 off): 2 days allows substantial receptor recovery
- Stamets (4 on, 3 off): 3 days off after 4 consecutive days; note that by day 4, significant tolerance has developed
- Every other day: 1 day allows partial but not complete recovery
Tolerance as feedback
- Effects fading during a protocol? → Your rest days may be insufficient
- Effects stronger after a long break? → Confirms tolerance was building up
- No difference between on and off days? → Either tolerance is high, or the dose is too low, or benefits have integrated into baseline
The Stamets Stack debate
Some critics of the Stamets Protocol (4 on, 3 off) argue that significant tolerance develops by day 3–4, potentially making the last dosing days less effective. Proponents counter that the Lion's Mane and niacin components work through different mechanisms not subject to 5-HT2A tolerance.
Tolerance myths
"I can overcome tolerance by increasing the dose"
Technically true but strongly inadvisable. Dose escalation:
- Defeats the purpose of sub-perceptual dosing
- Can lead to unexpectedly strong experiences
- Doesn't address the underlying receptor issue
- Creates a problematic pattern
"Switching substances avoids tolerance"
False. Cross-tolerance means that tolerance to psilocybin equals tolerance to LSD, mescaline, and all other 5-HT2A agonists.
"I don't develop tolerance"
Unlikely. Receptor downregulation is a universal biological mechanism. If you don't notice tolerance, it may be because:
- Your effects were primarily expectancy/placebo-driven (unaffected by pharmacological tolerance)
- Your protocol has adequate rest days
- You're not tracking carefully enough to detect the change